SAB Biotherapeutics, Inc. - COM NEW (SABS)

Historical Portfolio Holders from Q4 2023 to Q2 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM NEW
Shares, excl. options Q2 2024
3.13M
Holdings value Q2 2024
$9.69M
Value change Q2 2024
-$924K
Grand Portfolio weight change Q2 2024
0%
Number of holders
21
Number of buys Q2 2024
7
Number of sells Q2 2024
-8
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 3.13M $9.69M -$924K $3.10 21
2024 Q1 3.34M $15.2M -$15.6M $4.54 23
2023 Q4 8.79M $6.06M +$6.06M $0.69 3